The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. 4 When the catheter is introduced to the vascular system, the location of the balloon should be confirmed while under fluoroscopic observation. 3. This unique mechanism of action aims at providing improved acute and long term outcomes while leaving nothing behind. … Fonseca A, Costa JR, Abizaid A, et al. AngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. Part (REF) Number Product Description Lot Numbers 2076-4020 AngioSculpt PTA Scoring Balloon Catheter, OTW 0.018” Platform, 137 cm, 4.0mmx20mm balloon size All 2076-5020 AngioSculpt PTA Scoring Balloon Catheter, OTW 0.018” Platform, 137 cm, 5.0mmx20mm balloon size All 2076 … Catalog Number: 2200-3510. The AngioSculpt Scoring Balloon Catheters represent the next generation in angioplasty catheters for both coronary and peripheral artery disease. AngioSculpt® PTA Scoring Balloon Catheter (Philips, Japan, Inc.) was developed as an effective device for patients with advanced stenotic lesions in which conven-tional PTA balloons are unable to achieve favorable patency because of their insufficient expansion. “The AngioSculpt Scoring Balloon Catheter represents a significant advance in the treatment of challenging coronary and peripheral lesions. Company Name: Spectranetics Corporation. American Journal of Cardiology September 2003; Vol. Catheter Cardiovasc Interv. Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring. Primary efficacy endpoint is late lumen loss in-segment at 6 months. The use of DEBs or stent implantation after scoring balloon angioplasty was performed at the discretion of the interventionist. The AngioSculpt PTA scoring balloon catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The AngioSculpt balloon catheter was developed by AngioScore, Inc., which was acquired June 30, 2014, by The Spectranetics Corporation. It is not, however, fully elucidated whether AngioSculpt for advanced vascular access stenosis, difficult to expand by conventional balloons, successfully provides bailout angioplasty. The result is an essential tool in . The AngioSculpt device measures approximately 137 cm in length and is available in diameters from 2 to 3.5 mm in increases of 0.5 mm. Mooney M, Teirstein P, Moses Intravascular ultrasound assessment of the novel AngioSculpt Scoring Balloon Catheter for the treatment of complex coronary lesions. 1 Fonseca A, Costa JR, Abizaid A, et al. The AngioSculpt PTA scoring balloon catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Designed to address a wide range of peripheral lesions— including the long, diffuse lesions commonly found in … The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. The recall affects 17,682 AngioSculpt PTA scoring balloon catheters (OTW 0.018" Platform) of multiple sizes, including all sizes and lot codes for … 2008; 20: 21-27; 2. The AngioSculpt (AngioScore Inc., Fremont, CA, USA) was developed as a coronary interventional device, which consists of a semi-compliant balloon surrounded by spiral nitinol element that works in tandem with the balloon in order to ‘score’ the target lesion upon balloon inflation 1, 2 . Source: AngioScore, Inc. Brief Summary: The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in … The AngioSculpt Scoring Balloon Catheter is a line of innovative angioplasty catheters comprising an angioplasty balloon surrounded by a unique system of nitinol scoring elements. This FIH trial of a novel drug-coated scoring balloon will enroll 60 patients … The useful … The AngioSculpt Scoring Balloon Catheter (AngioScore, Inc., Fremont, CA) is composed of a semicompliant balloon encircled by three nitinol spiral struts providing targeted lesion scoring on balloon inflation. Spectranetics president and CEO Scott Drake said: "Now, united with AngioScore, we continue our commitment to provide solutions to cross, prep and treat the most complex morphologies associated with coronary … The longer length of Philips AngioSculpt provides more coverage and convenience for infrainguinal artery procedures, but it’s the unique advantage of the AngioSculpt scoring … 1. AngioSculpt’s smart scoring balloon technology delivers a unique combination of controlled, effective dilatation and predictable device safety. The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. The AngioSculpt catheter should not be used for coronary artery lesions The AngioSculpt PTA Scoring Balloon Catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. The product assists physicians with a difficult patient set, targeting lesions in the hemodialysis access that are resistant to standard balloon angioplasty. AngioSculpt® Scoring Balloon Catheter Multi-Center Coronary Bifurcation Study Sponsors: Lead Sponsor: AngioScore, Inc. 2 MB. Especially indicated for in-stent restenosis, bifurcations and small vessels. The aim is to examine the treatment of coronary Bare Metal Stent restenosis with a drug coated AngioSculpt scoring balloon. The AngioSculpt RX PTCA scoring balloon catheter is the only specialty scoring device indicated for … Brand Name: AngioSculpt®PTCA Scoring Balloon Catheter. The catheter is compatible with standard 0.36mm (0.014″) coronary guidewires and 6F guiding catheters. AngioSculpt PTA Scoring Balloon Catheter. 2008;20:21-27. AngioSculpt Test Plan ST-1197 (2008), on file at AngioScore, Inc. 4. The AngioSculpt device measures approximately 137 cm in length and is available in diameters from 2 to 3.5 mm in increases of 0.5 mm. It is not, however, fully elucidated whether AngioSculpt for advanced vascular access stenosis, difficult to expand by conventional balloons, successfully provides bailout angioplasty. A nitinol scoring element-equipped helical balloon catheter (AngioSculpt ®) has been altered the landscape for treating several vascular diseases. Catheter Cardiovasc Interv. The AngioSculpt PTCA scoring balloon catheter is an essential tool in the treatment of a wide range of coronary lesions, including in-stent restenosis (ISR) and type C lesions. Commercial Distribution Status: In Commercial Distribution. GEOALIGN ® Markers are not a replacement for fluoroscopy. - Product Code NWX. Patients are randomized to treatment by an AngioSculpt scoring balloon (no drug coating)or a drug coated AngioSculpt scoring balloon (paclitaxel 3.0 µg/mm²). Not for use in the coronary or 26. Spectranetics AngioSculpt PTCA Scoring Balloon Catheter, balloon outer diameter 2.5mm, balloon length 15mm, REF 2027-2515, Sterile, Rx. 92, Issue 6, Supplement 1: 166L. Designed specifically to address complex lesions found in infrainguinal arteries, the AngioSculpt PTA scoring balloon catheter offers 360˚ of precise and effective dilatation. A Novel Angioplasty Catheter For The Treatment Of Complex CAD: AngioSculpt®. AngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. "In spite of advances in medical device technology, maintaining hemodialysis access function … Product. Not for use in the coronary or Version or Model: 2200-3510. The AngioSculpt (AngioScore Inc., Fremont, CA, USA) was developed as a coronary interventional device, which consists of a semi-compliant balloon surrounded by spiral nitinol element that works in tandem with the balloon in order to ‘score’ the target lesion upon balloon inflation 1, 2 (Fig. Fonseca A, Costa JR, Abizaid A, et al. The AngioSculpt PTCA scoring balloon catheter is an essential tool in the treatment of a wide range of coronary lesions, including in-stent restenosis (ISR) and type C lesions. Not for use in the coronary or This unique mechanism of action aims at providing improved acute and long term outcomes while leaving … The AngioSculpt Scoring Balloon Catheter is a new tool in the treatment of simple to complex lesions, including in-stent restenosis (ISR) and type C lesions. The AngioSculpt™ scoring balloon catheter (AngioScore, Inc., Fremont, California) has recently been developed for percutaneous intervention in coronary and peripheral arteries. AngioSculpt X is the first treatment to combine the scoring effect and drug release in a single device. The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. Between April 2005 and April 2006, procedural and … The AngioSculpt Scoring Balloon Catheter represents the next generation in angioplasty catheters. The AngioSculpt Scoring Balloon Catheter is an essential tool for the treatment of both coronary and peripheral artery disease. The idea is to provide controlled predictable scoring of the artery wall to allow better dilatation with the semi compliant balloon. Designed specifically to address long, diffuse lesions commonly found in infrainguinal arteries, the AngioSculpt PTA scoring balloon catheter offers 360˚ of precise and effective dilatation. Based on the innovative AngioSculpt platform, the balloon catheter is coated with a specialised formula that includes the antiproliferative drug Paclitaxel. AngioSculpt Scoring Balloon PTCA, RX, … AngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. Company Name: Spectranetics Corporation. AngioSculpt can be used in treating fibro-calcific, bifurcation and ostial lesions. Primary … The firm name on the label is Spectranetics Corporation, Fremont, CA. This device is composed of two major components, a minimally compliant balloon and three nitinol wore. 25. The AngioSculpt scoring balloon catheter is indicated for use in the treatment of hemodynamically significant coronary artery stenosis, including in-stent restenosis and complex type C lesions, for the purpose of improving myocardial perfusion. 2008; 20: 21-27; 2 Mooney M, Teirstein P, Moses J, et al. AngioSculpt delivers a unique combination of controlled, effective dilatation and predictable device safety. The AngioSculpt Scoring Balloon Catheter (AngioScore, Inc., Fremont, CA) is composed of a semicompliant balloon encircled by three nitinol spiral struts providing targeted lesion scoring on balloon inflation. Designed specifically to address long, diffuse lesions commonly found in infrainguinal arteries, the AngioSculpt PTA scoring balloon catheter offers 360˚ of precise and effective dilatation. AngioSculpt’s smart scoring balloon technology delivers a unique combination of controlled, effective dilatation and predictable device safety. The AngioSculpt RX PTCA Scoring Balloon Catheter delivers the proven advantages of the AngioSculpt system combined with a new, tapered tip design that enhances deliverability. Over 60,000 unopened, expired and non-expired medical products 100+ OEMs available at 50%-90% below MSRP Non-clinical R&D, Research, Bench Testing, Sales and Teaching. The product assists physicians with a difficult patient set, targeting lesions in the hemodialysis access that are resistant to standard balloon … FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced today that its AngioSculpt® Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Catheter has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the device for balloon dilatation … AngioSculpt Test Plan ST-1197 (2008), on file at AngioScore, Inc. 4. 2. AngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. J Invasive Cardiol. If you reside inside the United States, please visit our United States IFU Library. Catheter Cardiovasc Interv. The catheter is supplied sterile, protected with an inner guide and an outer plastic sheath that guarantees its protection. The AngioSculpt Scoring Balloon Catheter (AngioScore, Inc., Fremont, CA) is composed of a semicompliant balloon encircled by three nitinol spiral struts providing targeted lesion scoring on balloon inflation. The AngioSculpt RX PTCA scoring balloon catheter is the only specialty scoring device indicated for … the treatment of a wide range of coronary lesions, including in-stent restenosis (ISR) and type C lesions. The AngioSculptX Drug-Coated PTCA Scoring Balloon Catheter is built on the trusted AngioSculpt scoring balloon platform and is designed for lumen gain through controlled dissection with enhanced drug delivery. Version or Model: 2001-2010. Fonseca A, Costa JR, Abizaid A, et al. AngioScore’s PMA clinical trial and other studies demonstrated the ability of the AngioSculpt to achieve more predictable luminal expansion, avoid slippage or … A nitinol scoring element-equipped helical balloon catheter (AngioSculpt®) has been altered the landscape for treating several vascular diseases. Patients are randomized to treatment by an AngioSculpt scoring balloon (no drug coating)or a drug coated AngioSculpt scoring balloon (paclitaxel 3.0 µg/mm²). AngioSculpt ®X Drug-Coated PTCA Scoring Balloon Catheter, Outsert. Brand Name: AngioSculpt®PTCA Scoring Balloon Catheter. 945 KB. Ultimately, compression of the thrombus with the AngioSculpt™ scoring balloon catheter (AngioScore, Fremont, CA) led to resolution of normal coronary flow without the need for implantation of a coronary stent. J Invasive Cardiol. The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the … J Invasive Cardiol. 2007;70:1034-1039. Animal study (repeat PTA in swine artery) was performed by 3 physicians who tested the LUTONIX ® 035 (no drug) and the ULTRAVERSE ® 035 PTA Catheter… J Invasive Cardiol. The AngioSculpt PTA scoring balloon catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The AngioSculpt Scoring Balloon Catheter combines the safety and effectiveness required of a new technology with the simplicity and versatility of a high-performance balloon catheter. BIOTRONIK is the distributor of AngioSculpt on behalf of Angioscore/Spectranetics. Loading...
Physical Intimacy Scale,
Sherpa Definition Synonym,
Self-assessment Techniques,
Spanish Mediterranean Interior Design,
Intuitive Tennis Location,
End Of Life Planning Workbook Pdf,
Forza Horizon 2 Best Rally Car,
Boston University Application Fee Waiver Code,